Compare LW & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LW | APGE |
|---|---|---|
| Founded | 1950 | 2022 |
| Country | United States | United States |
| Employees | 10100 | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 2016 | 2023 |
| Metric | LW | APGE |
|---|---|---|
| Price | $44.73 | $89.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | $44.14 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.2M | 1.0M |
| Earning Date | 04-01-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.26 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.62 | $34.34 |
| 52 Week High | $67.07 | $95.32 |
| Indicator | LW | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 58.50 | 58.46 |
| Support Level | $39.96 | $73.70 |
| Resistance Level | $46.61 | $93.61 |
| Average True Range (ATR) | 1.12 | 5.02 |
| MACD | 0.22 | 0.62 |
| Stochastic Oscillator | 80.46 | 89.73 |
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.